Joinn Laboratories(China)Co (SHG:603127) — Market Cap & Net Worth
Market Cap & Net Worth: Joinn Laboratories(China)Co (603127)
Joinn Laboratories(China)Co (SHG:603127) has a market capitalization of $2.99 Billion (CN¥20.41 Billion) as of June 17, 2026. Listed on the SHG stock exchange, this China-based company holds position #5028 globally and #932 in its home market, demonstrating a 3.22% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Joinn Laboratories(China)Co's stock price CN¥32.38 by its total outstanding shares 630353014 (630.35 Million). Review debt load of Joinn Laboratories(China)Co to assess the company's total debt and financial obligations.
Joinn Laboratories(China)Co Market Cap History: 2017 to 2026
Joinn Laboratories(China)Co's market capitalization history from 2017 to 2026. Data shows growth from $655.91 Million to $2.99 Billion (34.95% CAGR).
Joinn Laboratories(China)Co Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Joinn Laboratories(China)Co's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.95x
Joinn Laboratories(China)Co's market cap is 1.95 times its annual revenue
Latest Price to Earnings (P/E) Ratio
10.84x
Joinn Laboratories(China)Co's market cap is 10.84 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $655.91 Million | $301.28 Million | $76.45 Million | 2.18x | 8.58x |
| 2018 | $791.19 Million | $408.80 Million | $108.34 Million | 1.94x | 7.30x |
| 2019 | $1.35 Billion | $639.38 Million | $186.77 Million | 2.12x | 7.25x |
| 2020 | $3.39 Billion | $1.08 Billion | $315.01 Million | 3.15x | 10.77x |
| 2021 | $5.33 Billion | $1.52 Billion | $557.46 Million | 3.51x | 9.56x |
| 2022 | $3.79 Billion | $2.27 Billion | $1.07 Billion | 1.67x | 3.53x |
| 2023 | $2.19 Billion | $2.38 Billion | $396.99 Million | 0.92x | 5.51x |
| 2024 | $1.53 Billion | $2.02 Billion | $74.08 Million | 0.76x | 20.71x |
| 2025 | $3.23 Billion | $1.66 Billion | $297.84 Million | 1.95x | 10.84x |
Competitor Companies of 603127 by Market Capitalization
Companies near Joinn Laboratories(China)Co in the global market cap rankings as of June 17, 2026.
Key companies related to Joinn Laboratories(China)Co by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #127 globally with a market cap of $177.57 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #182 globally with a market cap of $128.10 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #626 globally with a market cap of $44.18 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #663 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #127 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.57 Billion | $472.63 |
| #182 | Danaher Corporation | NYSE:DHR | $128.10 Billion | $181.35 |
| #626 | IDEXX Laboratories Inc | NASDAQ:IDXX | $44.18 Billion | $573.00 |
| #663 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Joinn Laboratories(China)Co Historical Marketcap From 2017 to 2026
Between 2017 and today, Joinn Laboratories(China)Co's market cap moved from $655.91 Million to $ 2.99 Billion, with a yearly change of 34.95%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥2.99 Billion | -7.51% |
| 2025 | CN¥3.23 Billion | +110.52% |
| 2024 | CN¥1.53 Billion | -29.86% |
| 2023 | CN¥2.19 Billion | -42.30% |
| 2022 | CN¥3.79 Billion | -28.86% |
| 2021 | CN¥5.33 Billion | +57.06% |
| 2020 | CN¥3.39 Billion | +150.67% |
| 2019 | CN¥1.35 Billion | +71.05% |
| 2018 | CN¥791.19 Million | +20.62% |
| 2017 | CN¥655.91 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Joinn Laboratories(China)Co was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.99 Billion USD |
| MoneyControl | $2.99 Billion USD |
| MarketWatch | $2.99 Billion USD |
| marketcap.company | $2.99 Billion USD |
| Reuters | $2.99 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Joinn Laboratories(China)Co
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics… Read more